Exploration Risks Loom as Red Mountain Awaits Critical Assay Results
Red Mountain Mining has launched an expanded exploration program at its Armidale Antimony-Gold Project, revealing promising visible antimony mineralisation early in the campaign. The company aims to define drill targets for 2026 following extensive soil and auger sampling.
- Expanded exploration underway at Oaky Creek prospect
- Visible stibnite and stibiconite mineralisation identified early
- Approximately 900 auger samples planned by December 2025
- Assay results expected by March 2026 to guide drilling
- Successful $1.35 million placement to fund exploration
Exploration Accelerates at Oaky Creek
Red Mountain Mining Ltd (ASX, RMX) has kicked off an expanded exploration program at the Oaky Creek prospect, part of its 100%-owned Armidale Antimony-Gold Project in New South Wales. Early fieldwork has already yielded encouraging results, with visible stibnite and stibiconite mineralisation discovered within the first two days of sampling. These minerals are key sources of antimony, a critical mineral with growing strategic importance.
The program focuses on a 1.2-kilometre strike zone at Oaky Creek North, where soil anomalies rich in antimony have been identified. The company plans to collect around 900 hand-auger samples by December 2025, with assay results expected by the end of the March quarter in 2026. These results will inform the prioritisation of drill targets for the first half of next year.
Strategic Location and Geological Context
The Armidale project lies within the New England Orogen, Australia's premier antimony province, and is geologically analogous to the nearby Hillgrove deposit, Australia's largest antimony-gold resource. The project covers nearly 400 square kilometres of highly prospective ground along the Peel Fault system, which hosts numerous orogenic gold and antimony occurrences.
Historical workings at Oaky Creek date back to the late 19th century but have seen limited modern exploration. Red Mountain's recent soil and rock chip sampling has delineated a coherent antimony-gold mineral system extending over 3 kilometres, with rock chip samples returning high-grade antimony values up to 39.3% Sb and associated gold.
Funding and Forward Plans
Supporting this accelerated exploration push, Red Mountain successfully raised $1.35 million through a heavily oversubscribed placement to sophisticated and family office investors. The funds will underpin ongoing work at Armidale and the company's US critical minerals portfolio, which includes projects in Utah, Idaho, and Nevada.
Alongside the soil sampling, the company is commissioning a high-resolution airborne magnetic-radiometric survey to better map structural features and refine target generation across the tenement. This integrated approach aims to fast-track the identification of drill-ready targets and expand the understanding of the project's mineral potential.
Implications for Critical Minerals Supply
Antimony is a critical mineral used in flame retardants, batteries, and alloys, with supply chains under pressure globally. Red Mountain's progress at Armidale positions it as a potential future supplier from a Tier-1 mining jurisdiction. The company's dual focus on Australian and US assets aligns with broader strategic efforts to secure reliable sources of critical minerals for Western markets.
While assay results are pending and drilling plans hinge on forthcoming data, the early discovery of visible high-grade antimony mineralisation is a promising indicator. Investors and analysts will be watching closely as Red Mountain advances its exploration and moves toward resource definition.
Bottom Line?
Red Mountain’s early exploration success at Armidale sets the stage for a pivotal 2026 drilling campaign that could reshape its critical minerals outlook.
Questions in the middle?
- Will assay results confirm the high-grade antimony indicated by visual estimates?
- How extensive is the mineralisation along the 3km strike at Oaky Creek?
- What are the timelines and scale for planned drilling following assay results?